IDO-IN-2
- CAS No.
- 1668565-74-9
- Chemical Name:
- IDO-IN-2
- Synonyms
- DO-IN-2;PCC0208009;IDO inhibitor 2;PCC0208009, 10 mM in DMSO;1-(4-(diisobutylamino)-2'-(1H-tetrazol-5-yl)biphenyl-3-yl)-3-p-tolylurea;1-(4-(Diisobutylamino)-2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-3-yl)-3-(p-tolyl)urea;Urea, N-[4-[bis(2-methylpropyl)amino]-2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]-N'-(4-methylphenyl)-;PCC0208009,IDO,PCC-0208009,Inhibitor,Indoleamine 2,3-Dioxygenase (IDO),PCC 0208009,inhibit,neuropathic
- CBNumber:
- CB43156650
- Molecular Formula:
- C29H35N7O
- Molecular Weight:
- 497.63
- MDL Number:
- MOL File:
- 1668565-74-9.mol
IDO-IN-2 price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-6165 | PCC0208009 99.65% | 1668565-74-9 | 2mg | $70 | 2021-12-16 | Buy |
ChemScene | CS-6165 | PCC0208009 99.65% | 1668565-74-9 | 5mg | $120 | 2021-12-16 | Buy |
ChemScene | CS-6165 | PCC0208009 99.65% | 1668565-74-9 | 10mg | $190 | 2021-12-16 | Buy |
ChemScene | CS-6165 | PCC0208009 99.65% | 1668565-74-9 | 50mg | $590 | 2021-12-16 | Buy |
DC Chemicals | DC10421 | IDO-IN-2 >98% | 1668565-74-9 | 100mg | $650 | 2021-12-16 | Buy |
IDO-IN-2 Chemical Properties,Uses,Production
Uses
PCC0208009 is a potent IDO inhibitor with an IC50 value of 4.52 nM in HeLa cell. PCC0208009 alleviates neuropathic pain and comorbidities by regulating synaptic plasticity of anterior cingulate cortex (ACC) and amygdala [1][2].
in vivo
PCC0208009 (single oral gavage; 50 mg/kg) in adult male Sprague Dawley rats (180 g-200 g) is detected at 60, 120 and 240 min after drug administration in plasma and brain samples, and the highest concentrations of PCC0208009 in plasma and brain are observed at 60 min after administration. Concomitantly, the Kyn/Trp ratio decreases at 60, 120 and 240 min postdose, with the minimum level in the plasma and the brain seen at 60 min post-dose[1].
PCC0208009 (oral gavage; once; 12-50 mg/kg) in adult male Sprague Dawley rats (180 g-200 g) is detected at 30, 60 and 90min after administration to evaluate the antinociceptive effects of PCC0208009 on neuropathic pain[1].
Animal Model: | Adult male Sprague Dawley rats (180 g-200 g) [1] |
Dosage: | 50 mg/kg |
Administration: | Single oral gavage |
Result: | The highest concentrations of PCC0208009 in plasma and brain were observed at 60 min after administration. |
Animal Model: | Adult male Sprague-Dawley rats bearing spinal nerve ligation (SNL)[1] |
Dosage: | 12.5 mg/kg, 25 mg/kg, 50 mg/kg |
Administration: | oral gavage; once |
Result: | Showed the behavioral tests and the timelines. |
IC 50
IDO: 4.52 nM (IC50, in HeLa cell)
References
[1] Yu Wang, et al. PCC0208009, an indirect IDO1 inhibitor, alleviates neuropathic pain and co-morbidities by regulating synaptic plasticity of ACC and amygdala. Biochem Pharmacol. 2020 Jul;177:113926. DOI:10.1016/j.bcp.2020.113926
[2] David K Williams, et al. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Bioorg Med Chem Lett. 2018 Feb 15;28(4):732-736. DOI:10.1016/j.bmcl.2018.01.010
[3] Shanyue Sun, et al. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models. Int J Immunopathol Pharmacol. Jan-Dec 2018;32:2058738418787991. DOI:10.1177/2058738418787991
IDO-IN-2 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29807 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32268 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
Nanjing Doge Biomedical Technology Co., Ltd | +86-25-58227606 +86-15305155328 | sales@dogechemical.com | China | 4128 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38663 | 58 | |
Shanghai Qianyi New Material Co., Ltd. | +8618083322317 | 3391883138@qq.com | China | 878 | 58 |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8615965530500 | nickzhang@hangyubiotech.com | China | 10983 | 58 |
View Lastest Price from IDO-IN-2 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2025-04-29 | PCC0208009
1668565-74-9
|
US $54.00-153.00 / mg | 99.89% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2020-02-01 | IDO-IN-2
1668565-74-9
|
US $1.00 / KG | 1KG | Min98% HPLC | g/kg/ton | Career Henan Chemical Co |
-
- PCC0208009
1668565-74-9
- US $54.00-153.00 / mg
- 99.89%
- TargetMol Chemicals Inc.
-
- IDO-IN-2
1668565-74-9
- US $1.00 / KG
- Min98% HPLC
- Career Henan Chemical Co